Literature DB >> 18751381

Regulation of inflammation- and angiogenesis-related gene expression in breast cancer cells and co-cultured macrophages.

Giselle T Burnett1, Denise C Weathersby, Tiffany E Taylor, Theodore A Bremner.   

Abstract

BACKGROUND: Tumor-associated macrophages (TAMs) secrete key modifiers of tumor progression and their modification has been proposed as a therapeutic strategy. Phenotypic changes that may render TAMs selectively vulnerable to anti-cancer agents were examined.
MATERIALS AND METHODS: Gene arrays, reverse transcription-polymerase chain reaction and Western blotting were used to study inflammation- and angiogenesis-related gene expression in co-cultured breast cancer cells and macrophages and to determine how their interactions were affected by tamoxifen and aspirin.
RESULTS: MCF-7 (mammary adenocarcinoma) cells down-regulated macrophage migration inhibitory factor (MIF), but tamoxifen-pretreated MCF-7 cells up-regulated MIF in co-cultured macrophages. Two molecular variants of MIF were observed in the co-cultured MCF-7 cells. Aspirin induced IL-10 expression in the macrophages, MCF-7 and tamoxifen-pretreated MCF-7 cells. Aspirin-pretreated macrophages potently induced IL-10 expression in the MCF-7 cells.
CONCLUSION: Because MIF is a determinant of the M1 macrophage activation state, the MCF-7-induced ablation of MIF in TAMs is suggestive of partial M2 polarization. Tamoxifen modulates MCF-7 regulation of TAM gene expression and aspirin alters macrophage regulation of MCF-7 gene expression.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18751381

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  7 in total

1.  Inflammation and colorectal cancer: does aspirin affect the interaction between cancer and immune cells?

Authors:  Michael Bergman; Meir Djaldetti; Hertzel Salman; Hanna Bessler
Journal:  Inflammation       Date:  2011-02       Impact factor: 4.092

2.  Two-phase dynamics of p53 in the DNA damage response.

Authors:  Xiao-Peng Zhang; Feng Liu; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2011-05-16       Impact factor: 11.205

3.  An antimicrobial peptide regulates tumor-associated macrophage trafficking via the chemokine receptor CCR2, a model for tumorigenesis.

Authors:  Ge Jin; Hameem I Kawsar; Stanley A Hirsch; Chun Zeng; Xun Jia; Zhimin Feng; Santosh K Ghosh; Qing Yin Zheng; Aimin Zhou; Thomas M McIntyre; Aaron Weinberg
Journal:  PLoS One       Date:  2010-06-08       Impact factor: 3.240

4.  A whole-cell tumor vaccine modified to express fibroblast activation protein induces antitumor immunity against both tumor cells and cancer-associated fibroblasts.

Authors:  Meihua Chen; Rong Xiang; Yuan Wen; Guangchao Xu; Chunting Wang; Shuntao Luo; Tao Yin; Xiawei Wei; Bin Shao; Ning Liu; Fuchun Guo; Meng Li; Shuang Zhang; Minmin Li; Kexing Ren; Yongsheng Wang; Yuquan Wei
Journal:  Sci Rep       Date:  2015-09-23       Impact factor: 4.379

5.  Distribution and prognostic impact of microglia/macrophage subpopulations in gliomas.

Authors:  Pia S Zeiner; Corinna Preusse; Anna Golebiewska; Jenny Zinke; Ane Iriondo; Arnaud Muller; Tony Kaoma; Katharina Filipski; Monika Müller-Eschner; Simon Bernatz; Anna-Eva Blank; Peter Baumgarten; Elena Ilina; Anne Grote; Martin L Hansmann; Marcel A Verhoff; Kea Franz; Friedrich Feuerhake; Joachim P Steinbach; Jörg Wischhusen; Werner Stenzel; Simone P Niclou; Patrick N Harter; Michel Mittelbronn
Journal:  Brain Pathol       Date:  2019-01-15       Impact factor: 6.508

6.  Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer.

Authors:  Eva Verjans; Erik Noetzel; Nuran Bektas; Anke K Schütz; Hongqi Lue; Birgitt Lennartz; Arndt Hartmann; Edgar Dahl; Jürgen Bernhagen
Journal:  BMC Cancer       Date:  2009-07-14       Impact factor: 4.430

7.  Aspirin Disrupts the Crosstalk of Angiogenic and Inflammatory Cytokines between 4T1 Breast Cancer Cells and Macrophages.

Authors:  Chia-Chien Hsieh; Chih-Hsuan Wang
Journal:  Mediators Inflamm       Date:  2018-06-24       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.